These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8030550)

  • 21. Conjunctival epithelial cells from patients with Sjögren's syndrome inappropriately express major histocompatibility complex molecules, La(SSB) antigen, and heat-shock proteins.
    Yannopoulos DI; Roncin S; Lamour A; Pennec YL; Moutsopoulos HM; Youinou P
    J Clin Immunol; 1992 Jul; 12(4):259-65. PubMed ID: 1512299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From antigen presentation to T-cell activation.
    Lanzavecchia A
    Res Immunol; 1998; 149(7-8):626. PubMed ID: 9851512
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
    Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
    J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sialadenitis in IQI/Jic mice: a new animal model of Sjögren's syndrome.
    Saegusa J; Kubota H
    J Vet Med Sci; 1997 Oct; 59(10):897-903. PubMed ID: 9362038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sjögren's syndrome: pathogenesis.
    Tabbara K; Sharara N
    Eur J Ophthalmol; 1999; 9(1):1-7. PubMed ID: 10230585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunopathogenesis of Sjögren's syndrome.
    Moutsopoulos HM
    Isr J Med Sci; 1988 Dec; 24(12):737-9. PubMed ID: 3066783
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
    Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
    Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.
    Undale AH; van den Elsen PJ; Celis E
    Int Immunol; 2004 Oct; 16(10):1523-33. PubMed ID: 15351785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
    Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
    J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential MHC class II presentation of a pathogenic autoantigen during health and disease.
    Shih FF; Racz J; Allen PM
    J Immunol; 2006 Mar; 176(6):3438-48. PubMed ID: 16517712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An increase in peripheral blood Ia-positive T cells in Sjögren's syndrome correlates with a decrease in the autologous mixed lymphocyte response.
    Sauvezie B; Miyasaka N; Charron D; Kielich C; Loeb J; Daniels TE; Talal N
    Clin Exp Immunol; 1982 Jul; 49(1):50-8. PubMed ID: 6215195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter.
    Bakhshi A; Miyasaka N; Kavathas P; Daniels TE; Strand CV; Herzenberg LA; Talal N
    J Clin Lab Immunol; 1983 Feb; 10(2):63-9. PubMed ID: 6601716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation antigens in patients with Sjögren's syndrome.
    Zeher M; Pálóczi K; Szegedi G
    Haematologia (Budap); 1990; 23(4):193-7. PubMed ID: 2101803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of multiple class II signals by murine T cell antigen receptors. Speculation regarding the relationships among autoreactive, antigen-specific and alloreactive T cells.
    Needleman BW
    Immunol Res; 1988; 7(2):152-72. PubMed ID: 3292673
    [No Abstract]   [Full Text] [Related]  

  • 38. [Molecular mechanism on Sjögren's syndrome].
    Sumida T; Matsumoto I; Namekawa T; Kita Y
    Nihon Rinsho; 1995 Oct; 53(10):2395-400. PubMed ID: 8531344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.
    Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
    J Immunol; 2000 Aug; 165(4):2251-7. PubMed ID: 10925313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody.
    Hayashi Y; Ishimaru N; Arakaki R; Tsukumo S; Fukui H; Kishihara K; Shiota H; Yasutomo K; Hayashi Y
    Arthritis Rheum; 2004 Sep; 50(9):2903-10. PubMed ID: 15457459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.